Cargando…

Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine

The management of osteosarcoma (OS) patients presents a significant clinical challenge. Despite progress in conventional and targeted therapies, the survival rate of OS patients remains limited largely due to therapy resistance and the high metastatic potential of the disease. OS models that accurat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Linyun, Wang, Yitian, Hu, Xin, Du, Guifeng, Tang, Xiaodi, Min, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527053/ https://www.ncbi.nlm.nih.gov/pubmed/37759763 http://dx.doi.org/10.3390/biom13091362

Ejemplares similares

The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets
por: Tan, Linyun, et al.
Publicado: (2023)

Cementless curved endoprosthesis stem for distal femoral reconstruction in a Chinese population: a combined anatomical & biomechanical study
por: Hu, Xin, et al.
Publicado: (2022)

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
por: Tirtei, Elisa, et al.
Publicado: (2021)

Editorial: Computational Approaches in Drug Discovery and Precision Medicine
por: Huang, Zunnan, et al.
Publicado: (2021)

Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
por: Zeng, Chang, et al.
Publicado: (2019)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Recent advances of drug delivery nanocarriers in osteosarcoma treatment
por: Wang, Shang-Yu, et al.
Publicado: (2020)

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma
por: Zhu, Qian‐Ying, et al.
Publicado: (2021)

Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
por: Luu, Anita K., et al.
Publicado: (2021)

Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine
por: de Jong, Bart, et al.
Publicado: (2020)

The ACCOuNT Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans
por: Friedman, Paula N., et al.
Publicado: (2019)

High content screening for drug discovery from traditional Chinese medicine
por: Wang, Jing, et al.
Publicado: (2019)

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling
por: Ravichandran, Mirunalini, et al.
Publicado: (2023)

Drugging the epigenome in the age of precision medicine
por: Feehley, Taylor, et al.
Publicado: (2023)

DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
por: Agapito, Giuseppe, et al.
Publicado: (2020)

Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2022)

Translational Medicine and Drug Discovery
por: Tworkoski, Kathryn
Publicado: (2011)

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
por: Suehara, Yoshiyuki, et al.
Publicado: (2012)

Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery
por: Mehta, Pakhuri, et al.
Publicado: (2021)

Central resources of variant discovery and annotation and its role in precision medicine
por: Halim-Fikri, Hashim, et al.
Publicado: (2023)

Systems biology approaches for advancing the discovery of effective drug combinations
por: Ryall, Karen A, et al.
Publicado: (2015)

Advances in covalent drug discovery
por: Boike, Lydia, et al.
Publicado: (2022)

Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer
por: Jiang, Man, et al.
Publicado: (2021)

Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021)

High-throughput base editing: a promising technology for precision medicine and drug discovery
por: Sachinidis, Agapios
Publicado: (2021)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook
por: Prina-Mello, Adriele, et al.
Publicado: (2021)

Advances in the management of osteosarcoma
por: Bielack, Stefan S., et al.
Publicado: (2016)

Surgical Advances in Osteosarcoma
por: Brookes, Marcus J., et al.
Publicado: (2021)

Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine
por: Long, Nguyen Phuoc, et al.
Publicado: (2020)

Introduction to this Special Issue: “Biomarker Discovery and Precision Medicine”
por: Fang, Bingliang
Publicado: (2020)

Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer
por: Cui, Ze-Jia, et al.
Publicado: (2021)

Proteomics and Drug Repurposing in CLL towards Precision Medicine
por: Mavridou, Dimitra, et al.
Publicado: (2021)

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Advancing drug discovery using the power of the human genome
por: Heilbron, Karl, et al.
Publicado: (2021)

Recent advances in combinatorial biosynthesis for drug discovery
por: Sun, Huihua, et al.
Publicado: (2015)

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
por: Lai, Yurong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4g86fkfq1e0hk92csav8vn1cjv